Keiji Kurata

10PUBLICATIONS
39CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteinsGene and molecular therapyMolecular targetsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 29, 2024
Loss of GABARAP mediates resistance to immunogenic chemotherapy in multiple myeloma.

Annamaria Gulla, Eugenio Morelli, Megan Johnstone

|Feb 14, 2024
Epigenetic regulation of CD38/CD48 by KDM6A mediates NK cell response in multiple myeloma.

Jiye Liu, Lijie Xing, Jiang Li

|Dec 10, 2023
BCMA-targeted bortezomib nanotherapy improves therapeutic efficacy, overcomes resistance, and modulates the immune microenvironment in multiple myeloma.

Debasmita Dutta, Jiye Liu, Kenneth Wen

|Oct 27, 2023
Differentiation of BCMA-specific induced pluripotent stem cells into rejuvenated CD8αβ+ T cells targeting multiple myeloma.

Jooeun Bae, Shuichi Kitayama, Zach Herbert

|Feb 13, 2023
BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma.

Keiji Kurata, Mehmet K Samur, Priscilla Liow

|Feb 06, 2023
Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma.

Keiji Kurata, Anna James-Bott, Mark A Tye

Pageof 2

Frequent Collaborators

5 joint publications

Kenneth C Anderson

4 joint publications

Mehmet K Samur

4 joint publications

Jiye Liu

3 joint publications

Yu-Tzu Tai